Private company

MediXall Group, Inc.

MediXall Group, Inc. is an American railroads company, incorporated in Nevada.1 It is headquartered in Leesburg, Florida.1

Last updated Oct 21, 2026.

Overview

  • IndustryRailroads, Line-Haul Operating1
  • HeadquartersLeesburg, Florida1
  • Incorporated inNV2
  • Business address104 N 4Th St., Leesburg, Fl 347482
  • Filer categoryNon-accelerated filer, Smaller reporting company2

Behavioral 1 st Moment Solutions includes the following options to both our member and their immediate family:3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

23.6%Gross margin4
-1474.8%Net margin4
422.1%Revenue growth, 20234

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Cost of revenue76¢$236.5K
  • Other costs24¢$72.9K

Out of $309.4K in revenue.4 The company lost money this year.

Financial statements

Revenue567894$309.4K in 2023+1292% since 2017
0$100.0K$200.0K$300.0K$400.0K2017: $22.2K$22.2K20172018: $1.9K$1.9K2018−92%2019: $2.7K$2.7K2019+45%2020: $0$020202021: $180.7K$180.7K20212022: $59.3K$59.3K2022−67%2023: $309.4K$309.4K2023+422%
Gross profit4$72.9K in 2023+23% since 2022
0$20.0K$40.0K$60.0K$80.0K2022: $59.3K$59.3K20222023: $72.9K$72.9K2023+23%
Net income567894-$4.6M in 2023+193% since 2017
-$8.0M-$6.0M-$4.0M-$2.0M02017: -$1.6M-$1.6M20172018: -$3.0M-$3.0M2018+92%2019: -$3.4M-$3.4M2019+15%2020: -$5.9M-$5.9M2020+73%2021: -$6.2M-$6.2M2021+5%2022: -$6.8M-$6.8M2022+10%2023: -$4.6M-$4.6M2023−33%
Fiscal year2017201820192020202120222023
Revenue$22.2K5$1.9K6$2.7K7$08$180.7K9$59.3K4$309.4K4
Cost of revenue$04$236.5K4
Gross profit$59.3K4$72.9K4
Operating expenses$6.4M9$6.9M4$4.6M4
Operating income
Interest$09$271.1K9
Income before tax-$6.2M9-$6.8M4-$4.6M4
Income tax$08$09$04$04
Net income-$1.6M5-$3.0M6-$3.4M7-$5.9M8-$6.2M9-$6.8M4-$4.6M4
Earnings per share-$0.069-$0.064-$0.044
Earnings per share (diluted)-$0.069-$0.064-$0.044
Shares (weighted, basic)104.2M shares9116.7M shares4127.2M shares4
Shares (weighted, diluted)104.2M shares9116.7M shares4127.2M shares4

Compare MediXall Group, Inc. with another company

What it owns

What MediXall Group, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, net$13.5K4 Dec 31, 2023$21.8K4 Dec 31, 2022−38.0%
Operating-lease assets (leased space)$04 Dec 31, 2023$260.2K4 Dec 31, 2022−100.0%

Intangibles and goodwill

ItemLatestA year beforeChange
Intangible assets, net (excluding goodwill)$43.4K4 Dec 31, 2023$412.6K4 Dec 31, 2022−89.5%
Finite-lived intangibles, gross$156.0K4 Dec 31, 2023$188.7K4 Dec 31, 2022−17.3%
Accumulated amortization-$26.0K4 Dec 31, 2023-$32.7K4 Dec 31, 2022+20.5%
Finite-lived intangibles, net$130.0K4 Dec 31, 2023$156.0K4 Dec 31, 2022−16.7%

Properties, in its own words

We do not own any real property. The Company relocated and now has a 2-year renewable lease with TGRJR, LLC at 104 N 4th Street, Leesburg FL 34748, for which we pay approximately $1,113 per month, and a short-term lease with Regus at 2255 Glades Road, Boca Raton, FL 33431, for which we pay approximately $850 per month.

Item 2 of the 10-K filed Jan 27, 2025.3

Former names

  • CONTINENTAL RAIL CORPMar 5, 2014 to Nov 16, 20162

Timeline

  1. Apr 23, 20258-K Executive or director change12
  2. Dec 12, 20238-K Executive or director change13
  3. Dec 12, 20238-K Executive or director change14
  4. Oct 11, 20238-K Executive or director change15
  5. Jun 20, 20238-K Executive or director change16
  6. Jan 18, 20238-K Entered a material agreement17
  7. Dec 30, 20228-K Executive or director change18
  8. Sep 16, 20228-K Executive or director change19
  9. Sep 1, 20228-K Executive or director change20
  10. Jun 21, 20228-K Other events21
  11. Jun 15, 20228-K Executive or director change22

Filings

44 filings to the SEC since October 2021: 3 annual reports, 11 quarterly reports, 11 major events, 19 other. The latest 20:

  1. Aug 14, 2026NT 10-Q NOTIFICATION OF LATE FILING EDGAR
  2. May 15, 2026NT 10-Q NOTIFICATION OF LATE FILING EDGAR
  3. Mar 31, 2026NT 10-K NOTIFICATION OF LATE FILING EDGAR
  4. Nov 14, 2025NT 10-Q NOTIFICATION OF LATE FILING EDGAR
  5. Sep 8, 202510-Q EDGAR
  6. Aug 14, 2025NT 10-Q NOTIFICATION OF LATE FILING EDGAR
  7. Jun 5, 202510-Q EDGAR
  8. May 19, 202510-Q EDGAR
  9. May 15, 2025NT 10-Q NOTIFICATION OF LATE FILING EDGAR
  10. Apr 23, 20258-K EDGAR
  11. Apr 1, 2025NT 10-K NOTIFICATION OF LATE FILING EDGAR
  12. Jan 27, 202510-K EDGAR
  13. Nov 14, 2024NT 10-Q NOTIFICATION OF LATE FILING EDGAR
  14. Aug 15, 2024NT 10-Q NOTIFICATION OF LATE FILING EDGAR
  15. Jun 20, 202410-Q EDGAR
  16. Jun 6, 202410-Q EDGAR
  17. May 14, 202410-Q EDGAR
  18. Apr 1, 2024NT 10-K NOTIFICATION OF LATE FILING EDGAR
  19. Feb 12, 2024SEC STAFF ACTION EDGAR
  20. Dec 12, 20238-K EDGAR

The 44 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

SEC filer profile

How MediXall Group, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARMediXall Group, Inc.1
  • CIK0001601280
  • Employer ID (EIN)33-08641273
  • Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; a shell company3
  • Incorporated inNevada3
  • Fiscal year endsDecember 311
  • Industry code (SIC)4011 Railroads, Line-Haul Operating1
  • SEC reviewing officeOffice of Energy & Transportation, Division of Corporation Finance1
  • Business address104 N 4Th St., Leesburg, FL 347481
  • Phone800-381-17871
  • Shares outstanding205,506,008 as of Sep 2, 202511
  • Public float$95.9K as of Jun 30, 20243
  • AuditorHACKER, JOHNSON & SMITH PA, Fort Lauderdale, Florida PCAOB ID 4003
  • On EDGAR sinceMar 5, 20141
  • Filings118 in all: 10-Q (31), 8-K (24), NT 10-Q (19), 10-K (10), NT 10-K (10), S-1/A (5), CORRESP (4), 10-K/A (3)1
    All 14 form types

    10-Q/A (3), UPLOAD (3), 424B3 (2), S-1 (2), EFFECT (1), SEC STAFF ACTION (1)

  • Latest filingsAnnual report (10-K) Jan 27, 2025
    Quarterly report (10-Q) Sep 8, 2025
    Latest 8-K (8-K) Apr 23, 2025

Risk factors and legal proceedings

The risks MediXall Group, Inc. names in Item 1A of its 10-K filed Jan 27, 2025: 3 risks under these headings, as written.3

  • Before you invest in our securities, you should be aware that there are various risks. You should carefully consider these risk factors, together with all of the other information included in this Annual Report on Form 10-k before you decide to purchase our securities. If any of the following risks and uncertainties develop into actual events, our business, financial condition or results of operations could be materially adversely affected.
  • RISKS RELATED TO OUR BUSINESS
  • RISKS RELATED TO OUR COMMON STOCK
  • RISKS RELATED TO HEALTHCARE INDUSTRY
  • Our use and disclosure of personally identifiable information, including health information, and other personal data is subject to federal, state, and foreign privacy and security regulations, and our failure to comply with those regulations or to adequately secure the information we hold could result in significant liability or reputational harm and, in turn, a material adverse effect on our Client base, membership base, and revenue.
  • Changes to consumer privacy laws could adversely affect our ability to market our offerings effectively and may require us to change our business practices or expend significant amounts on compliance with such laws.

Legal proceedings

Various legal claims arise from time to time in the normal course of business which, in the opinion of management, will not have a material effect on the Company's consolidated financial statements. There are no material pending legal proceedings, other than ordinary routine litigation incidental to our business, to which we are a party or which our business or intellectual property is the subject. In addition, none of our officers, directors, affiliates or 5% stockholders (or any associates thereof) is a party adverse to us, or has a material interest adverse to us, in any material proceeding.

The opening of Item 3, Legal Proceedings.3